These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 32198907)
21. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study. Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674 [TBL] [Abstract][Full Text] [Related]
22. [Women´s preferences for prenatal tests A discrete choice experiment to contrast noninvasive prenatal testing with current invasive tests]. Ingvarsdottir S; Stefansdottir V; Gottfredsdottir H Laeknabladid; 2016 Jun; 102(6):277-82. PubMed ID: 27295145 [TBL] [Abstract][Full Text] [Related]
23. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives. van Schendel RV; Page-Christiaens GC; Beulen L; Bilardo CM; de Boer MA; Coumans AB; Faas BH; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MV; Oepkes D; Pajkrt E; Henneman L; Prenat Diagn; 2016 Dec; 36(12):1091-1098. PubMed ID: 27739584 [TBL] [Abstract][Full Text] [Related]
24. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center. Manegold-Brauer G; Berg C; Flöck A; Rüland A; Gembruch U; Geipel A Arch Gynecol Obstet; 2015 Sep; 292(3):543-8. PubMed ID: 25716672 [TBL] [Abstract][Full Text] [Related]
25. Uptake of fetal aneuploidy screening after the introduction of the non-invasive prenatal test: A national population-based register study. van der Meij KRM; de Groot-van Mooren M; Carbo EWS; Pieters MJ; Rodenburg W; Sistermans EA; Cornel MC; Henneman L; Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1265-1272. PubMed ID: 33465829 [TBL] [Abstract][Full Text] [Related]
26. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan. Shaw SW; Chen CP; Cheng PJ Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028 [TBL] [Abstract][Full Text] [Related]
27. Financial contribution as reason to opt out of non-invasive prenatal testing. Bet BB; Wielart L; Ravelli ACJ; van Wely M; van Leeuwen E; Pajkrt E Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():130-136. PubMed ID: 37311275 [TBL] [Abstract][Full Text] [Related]
28. Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands. Kristalijn SA; White K; Eerbeek D; Kostenko E; Grati FR; Bilardo CM BMC Pregnancy Childbirth; 2022 Oct; 22(1):782. PubMed ID: 36266611 [TBL] [Abstract][Full Text] [Related]
29. Use of the Combined First-Trimester Screen in High- and Low-Risk Patient Populations After Introduction of Noninvasive Prenatal Testing. Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ J Ultrasound Med; 2015 Aug; 34(8):1423-8. PubMed ID: 26206828 [TBL] [Abstract][Full Text] [Related]
30. Should cell-free fetal DNA be included in first trimester screening (FTS) for common trisomy? A possible scenario on 6697 women screened over 10 years. Rosignoli L; Tonni G J Eval Clin Pract; 2016 Dec; 22(6):899-906. PubMed ID: 27345561 [TBL] [Abstract][Full Text] [Related]
31. The influence of experiential knowledge and societal perceptions on decision-making regarding non-invasive prenatal testing (NIPT). Montgomery S; Thayer ZM BMC Pregnancy Childbirth; 2020 Oct; 20(1):630. PubMed ID: 33076858 [TBL] [Abstract][Full Text] [Related]
32. New screen on the block: non-invasive prenatal testing for fetal chromosomal abnormalities. Filoche S; Lawton B; Beard A; Dowell A; Stone P J Prim Health Care; 2017 Dec; 9(4):248-253. PubMed ID: 29530134 [TBL] [Abstract][Full Text] [Related]
33. Second tier non-invasive prenatal testing in a regional prenatal diagnosis service unit: a retrospective analysis and literature review. Ng VKS; Chan AL; Lau WL; Leung WC Hong Kong Med J; 2020 Feb; 26(1):10-18. PubMed ID: 32051331 [TBL] [Abstract][Full Text] [Related]
34. 1p deletion syndrome: A prenatal diagnosis characterized by an abnormal 1st trimester combined screening test, yet a normal NIPT result. Yang CY; Kao CC; Chang SD; Huang SY Taiwan J Obstet Gynecol; 2018 Feb; 57(1):106-109. PubMed ID: 29458877 [TBL] [Abstract][Full Text] [Related]
35. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals. Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550 [TBL] [Abstract][Full Text] [Related]
36. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies. O'Leary P; Maxwell S; Murch A; Hendrie D Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461 [TBL] [Abstract][Full Text] [Related]
37. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies. Audibert F; Gagnon A; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753 [TBL] [Abstract][Full Text] [Related]
38. Introduction of non-invasive prenatal testing as a first-tier aneuploidy screening test: A survey among Dutch midwives about their role as counsellors. Martin L; Gitsels-van der Wal JT; de Boer MA; Vanstone M; Henneman L Midwifery; 2018 Jan; 56():1-8. PubMed ID: 29024868 [TBL] [Abstract][Full Text] [Related]
39. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039 [TBL] [Abstract][Full Text] [Related]
40. False-positives and false-negatives in non-invasive prenatal testing (NIPT): what can we learn from a meta-analyses on > 750,000 tests? Liehr T Mol Cytogenet; 2022 Aug; 15(1):36. PubMed ID: 35986330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]